These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 39082335

  • 1. Role of Podocyte in Kidney Disease.
    Husain S.
    Front Biosci (Landmark Ed); 2024 Jul 11; 29(7):250. PubMed ID: 39082335
    [Abstract] [Full Text] [Related]

  • 2. Targeting podocyte-associated diseases.
    Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R.
    Adv Drug Deliv Rev; 2010 Nov 30; 62(14):1325-36. PubMed ID: 20828590
    [Abstract] [Full Text] [Related]

  • 3. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.
    Barisoni L, Schnaper HW, Kopp JB.
    Clin J Am Soc Nephrol; 2007 May 30; 2(3):529-42. PubMed ID: 17699461
    [Abstract] [Full Text] [Related]

  • 4. Nephrinuria and podocytopathies.
    Kostovska I, Trajkovska KT, Topuzovska S, Cekovska S, Labudovic D, Kostovski O, Spasovski G.
    Adv Clin Chem; 2022 May 30; 108():1-36. PubMed ID: 35659057
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The role of podocyte injury in chronic kidney disease].
    Asanuma K.
    Nihon Rinsho Meneki Gakkai Kaishi; 2015 May 30; 38(1):26-36. PubMed ID: 25765686
    [Abstract] [Full Text] [Related]

  • 8. The Pathology Lesion Patterns of Podocytopathies: How and why?
    Ravaglia F, Melica ME, Angelotti ML, De Chiara L, Romagnani P, Lasagni L.
    Front Cell Dev Biol; 2022 May 30; 10():838272. PubMed ID: 35281116
    [Abstract] [Full Text] [Related]

  • 9. Pathogenic role of TGF-β in the progression of podocyte diseases.
    Lee HS.
    Histol Histopathol; 2011 Jan 30; 26(1):107-16. PubMed ID: 21117032
    [Abstract] [Full Text] [Related]

  • 10. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy.
    Jiang H, Shen Z, Zhuang J, Lu C, Qu Y, Xu C, Yang S, Tian X.
    Front Immunol; 2023 Jan 30; 14():1335936. PubMed ID: 38288116
    [Abstract] [Full Text] [Related]

  • 11. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T, Ambrus L, Zákány N, Balla G, Bíró T.
    Acta Physiol Hung; 2015 Sep 30; 102(3):241-51. PubMed ID: 26551740
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Podocin and beta dystroglycan expression to study podocyte-podocyte and basement membrane matrix connections in adult protienuric states.
    Shankar PB, Nada R, Joshi K, Kumar A, Rayat CS, Sakhuja V.
    Diagn Pathol; 2014 Feb 21; 9():40. PubMed ID: 24559085
    [Abstract] [Full Text] [Related]

  • 14. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y, Pace J, Li Z, Ma'ayan A, Wang Z, Revelo MP, Chen E, Gu X, Attalah A, Yang Y, Estrada C, Yang VW, He JC, Mallipattu SK.
    J Am Soc Nephrol; 2018 Oct 21; 29(10):2529-2545. PubMed ID: 30143559
    [Abstract] [Full Text] [Related]

  • 15. Modulation of podocyte phenotype in collapsing glomerulopathies.
    Barisoni L, Kopp JB.
    Microsc Res Tech; 2002 May 15; 57(4):254-62. PubMed ID: 12012394
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
    Lee HS.
    Cell Tissue Res; 2012 Jan 15; 347(1):129-40. PubMed ID: 21541658
    [Abstract] [Full Text] [Related]

  • 17. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD, Poveda J, Sanz AB, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A.
    Biochim Biophys Acta; 2013 Dec 15; 1832(12):2232-43. PubMed ID: 23999007
    [Abstract] [Full Text] [Related]

  • 18. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
    Egerman MA, Wong JS, Runxia T, Mosoyan G, Chauhan K, Reyes-Bahamonde J, Anandakrishnan N, Wong NJ, Bagiella E, Salem F, Meliambro K, Li H, Azeloglu EU, Coca SG, Campbell KN, Raij L.
    FASEB J; 2020 Dec 15; 34(12):16191-16204. PubMed ID: 33070369
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.